|
1
|
Sirmans SM and Pate KA: Epidemiology,
diagnosis and management of polycystic ovary syndrome. Clin
Epidemiol. 6:1–13. 2013. View Article : Google Scholar
|
|
2
|
Raja-Khan N, Stener-Victorin E, Wu X and
Legro RS: The physiological basis of complementary and alternative
medicines for polycystic ovary syndrome. American journal of
physiology. Am J Physiol Endocrinol Metab. 301:E1–E10. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trivax B and Azziz R: Diagnosis of
polycystic ovary syndrome. Clin Obstet Gynecol. 50:168–177. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joham AE, Ranasinha S, Zoungas S, Moran L
and Teede HJ: Gestational diabetes and type 2 diabetes in
reproductive-aged women with polycystic ovary syndrome. J Clin
Endocrinol Metab. 99:447–452. 2014.
|
|
5
|
Nasrat H, Patra SK, Goswami B, Jain A and
Raghunandan C: Study of association of leptin and insulin
resistance markers in patients of PCOS. Indian J Clin Biochem.
31:104–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kao YH, Chiu WC, Hsu MI and Chen YJ:
Endothelial progenitor cell dysfunction in polycystic ovary
syndrome: Implications for the genesis of cardiovascular diseases.
Int J Fertil Steril. 6:208–213. 2013.
|
|
7
|
Chang AY, Oshiro J, Ayers C and Auchus RJ:
Influence of race/ethnicity on cardiovascular risk factors in
polycystic ovary syndrome, the Dallas Heart Study. Clin Endocrinol
(Oxf). Nov 26–2015.Epub ahead of print. View Article : Google Scholar
|
|
8
|
Cheng C, Zhang H, Zhao Y, Li R and Qiao J:
Paternal history of diabetes mellitus and hypertension affects the
prevalence and phenotype of PCOS. J Assist Reprod Genet.
32:1731–1739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee YJ, Jeong JE, Joo JK and Lee KS: A
case of idiopathic intracranial hypertension associated with PCOS.
Clin Exp Obstet Gynecol. 42:547–549. 2015.PubMed/NCBI
|
|
10
|
Bazarganipour F, Ziaei S, Montazeri A,
Foroozanfard F, Kazemnejad A and Faghihzadeh S: Psychological
investigation in patients with polycystic ovary syndrome. Health
Qual Life Outcomes. 11:1412013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi X, Pang Y and Qiao J: Role of
Anti-Müllerian Hormone in the pathogenesis and pathophysiological
characteristics of polycystic ovary syndrome. Eur J Obstet Gynecol
Reprod Biol. 199:82–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding L, Gao F, Zhang M, Yan W, Tang R,
Zhang C and Chen ZJ: Higher PDCD4 expression is associated with
obesity, insulin resistance, lipid metabolism disorders, and
granulosa cell apoptosis in polycystic ovary syndrome. Fertil
Steril. Feb 8–2016.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palioura E and Diamanti-Kandarakis E:
Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals
(EDCs). Rev Endocr Metab Disord. Jan 29–2016.Epub ahead of print.
PubMed/NCBI
|
|
14
|
Rajender S, Carlus SJ, Bansal SK, Negi MP,
Sadasivam N, Sadasivam MN and Thangaraj K: Androgen receptor CAG
repeats length polymorphism and the risk of polycystic ovarian
syndrome (PCOS). PLoS One. 8:e757092013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gul OO, Cander S, Gul B, Acikgoz E,
Sarandol E and Ersoy C: Evaluation of insulin resistance and plasma
levels for visfatin and resistin in obese and non-obese patients
with polycystic ovary syndrome. Eur Cytokine Netw. 26:73–78.
2015.
|
|
16
|
Rice S, Elia A, Jawad Z, Pellatt L and
Mason HD: Metformin inhibits follicle-stimulating hormone (FSH)
action in human granulosa cells: Relevance to polycystic ovary
syndrome. J Clin Endocrinol Metab. 98:E1491–E1500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li D, Li C, Xu Y, Xu D, Li H, Gao L, Chen
S, Fu L, Xu X, Liu Y, et al: Differential expression of microRNAs
in the ovaries from letrozole-induced rat model of polycystic ovary
syndrome. DNA Cell Biol. Jan 8–2016.Epub ahead of print. View Article : Google Scholar
|
|
18
|
Ojeda-Ojeda M, Murri M, Insenser M and
Escobar-Morreale HF: Mediators of low-grade chronic inflammation in
polycystic ovary syndrome (PCOS). Curr Pharm Des. 19:5775–5791.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roth LW, McCallie B, Alvero R, Schoolcraft
WB, Minjarez D and Katz-Jaffe MG: Altered microRNA and gene
expression in the follicular fluid of women with polycystic ovary
syndrome. J Assist Reprod Genet. 31:355–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hossain MM, Cao M, Wang Q, Kim JY,
Schellander K, Tesfaye D and Tsang BK: Altered expression of miRNAs
in a dihydrotestosterone-induced rat PCOS model. J Ovarian Res.
6:362013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sang Q, Yao Z, Wang H, Feng R, Wang H,
Zhao X, Xing Q, Jin L, He L and Wu L: Identification of microRNAs
in human follicular fluid: Characterization of microRNAs that
govern steroidogenesis in vitro and are associated with poly-cystic
ovary syndrome in vivo. J Clin Endocrinol Metab. 98:3068–3079.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen YH, Heneidi S, Lee JM, Layman LC,
Stepp DW, Gamboa GM, Chen BS, Chazenbalk G and Azziz R: miRNA-93
inhibits GLUT4 and is overexpressed in adipose tissue of polycystic
ovary syndrome patients and women with insulin resistance.
Diabetes. 62:2278–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic acids research.
42:D78–D85. 2014. View Article : Google Scholar :
|
|
24
|
Yang JH, Li JH, Jiang S, Zhou H and Qu LH:
ChIPBase: A database for decoding the transcriptional regulation of
long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic
Acids Res. 41:D177–D187. 2013. View Article : Google Scholar :
|
|
25
|
Kaur S, Archer KJ, Devi MG, Kriplani A,
Strauss JF III and Singh R: Differential gene expression in
granulosa cells from polycystic ovary syndrome patients with and
without insulin resistance: Identification of susceptibility gene
sets through network analysis. J Clin Endocrinol Metab.
97:E2016–E2021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic acids research.
37:1–13. 2009. View Article : Google Scholar
|
|
27
|
Yang JH, Li JH, Jiang S, Zhou H and Qu LH:
ChIPBase: A database for decoding the transcriptional regulation of
long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic
Acids Res. 41:D177–D187. 2013. View Article : Google Scholar :
|
|
28
|
Raja-Khan N, Urbanek M, Rodgers RJ and
Legro RS: The role of TGF-β in polycystic ovary syndrome. Reprod
Sci. 21:20–31. 2014. View Article : Google Scholar
|
|
29
|
Uchimura K, Hayata M, Mizumoto T, Miyasato
Y, Kakizoe Y, Morinaga J, Onoue T, Yamazoe R, Ueda M, Adachi M, et
al: The serine protease prostasin regulates hepatic insulin
sensitivity by modulating TLR4 signalling. Nat Commun. 5:34282014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Solomon SS, Majumdar G, Martinez-Hernandez
A and Raghow R: A critical role of Sp1 transcription factor in
regulating gene expression in response to insulin and other
hormones. Life Sci. 83:305–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Anjali G, Kaur S, Lakra R, Taneja J,
Kalsey GS, Nagendra A, Shrivastav TG, Gouri Devi M, Malhotra N,
Kriplani A and Singh R: FSH stimulates IRS-2 expression in human
granulosa cells through cAMP/SP1, an inoperative FSH action in PCOS
patients. Cell Signal. 27:2452–2466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jansen E, Laven JS, Dommerholt HB, Polman
J, van Rijt C, van den Hurk C, Westland J, Mosselman S and Fauser
BC: Abnormal gene expression profiles in human ovaries from
polycystic ovary syndrome patients. Mol Endocrinol. 18:3050–3063.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee BS, Oh J, Kang SK, Park S, Lee SH,
Choi D, Chung JH, Chung YW and Kang SM: Insulin protects cardiac
myocytes from doxorubicin toxicity by Sp1-mediated transactivation
of survivin. PLoS One. 10:e01354382015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang X, Hao C, Shen X, Zhang Y and Liu X:
RUNX2, GPX3 and PTX3 gene expression profiling in cumulus cells are
reflective oocyte/embryo competence and potentially reliable
predictors of embryo developmental competence in PCOS patients.
Reprod Biol Endocrinol. 11:1092013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang A, Al-Kuhlani M, Johnston SC, Ojcius
DM, Chou J and Dean D: Transcription factor complex AP-1 mediates
inflammation initiated by Chlamydia pneumoniae infection. Cell
Microbiol. 15:779–794. 2013. View Article : Google Scholar :
|
|
36
|
Chazenbalk G, Chen YH, Heneidi S, Lee JM,
Pall M, Chen YD and Azziz R: Abnormal expression of genes involved
in inflammation, lipid metabolism and Wnt signaling in the adipose
tissue of polycystic ovary syndrome. J Clin Endocrinol Metab.
97:E765–E770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saikumar P, Selvi VK, Prabhu K, Venkatesh
P and Krishna P: Anti mullerian hormone: A potential marker for
recruited non growing follicle of ovarian pool in women with
polycystic ovarian syndrome. J Clin Diagn Res. 7:1866–1869.
2013.PubMed/NCBI
|
